Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feedergsk.com
Press releases
Get the latest updates from Press releases directly as they happen.
Follow now 565 followers
Latest posts
Last updated 9 days ago
TESARO, a GSK subsidiary, initiates litigation against AnaptysBio, Inc.
9 days ago
TESARO, Inc., confirms it has initiated litigation against AnaptysBio, Inc. in the...
GSK and LTZ announce strategic collaboration to advance novel myeloid cell engagers in oncology
10 days ago
Supports GSK's focus of using novel technologies in areas of disease expertise...
GSK and Fleming Initiative scientists unite to target AMR with advanced AI
11 days ago
£45m GSK funding allocated to 6 new research programmes combining expertise and...
GSK presents data from its advancing liver pipeline at AASLD 2025
22 days ago
21 abstracts highlight advances in the treatment of liver conditions, building from...
GSK delivers strong Q3 performance and upgrades 2025 guidance
about 1 month ago
Q3 2025 performance highlights
GSK and Empirico enter license agreement for clinical-stage, first-in-class oligonucleotide candidate to treat respiratory diseases
about 1 month ago
siRNA candidate EMP-012 in phase I for treatment of COPD.
GSK’s B7-H3-targeted antibody-drug conjugate, GSK’227, receives Orphan Drug Designation in the EU
about 1 month ago
Regulatory designation based on encouraging early clinical data showing potential for GSK’227...
GSK acquires exclusive rights from Syndivia for antibody-drug conjugate (ADC) in prostate cancer
about 1 month ago
ADC complements GSK’s diverse pipeline in prostate cancer anchored by GSK’227, a...
Blenrep approved by US FDA for use in treatment of relapsed/refractory multiple myeloma
about 1 month ago
Blenrep is the only anti-BCMA accessible in the community setting where 70%...
GSK announces positive pivotal phase III data for next-generation low carbon version of Ventolin (salbutamol) metered dose inhaler
about 1 month ago
Data confirm therapeutic equivalence and comparable safety profile for Ventolin (salbutamol) containing...
Positive PIVOT-PO phase III data show tebipenem HBr’s potential as the first oral carbapenem antibiotic for patients with complicated urinary tract infections (cUTIs)
about 1 month ago
Data presented at IDWeek 2025 after study stopped early for efficacy
GSK’s Shingrix new prefilled syringe presentation receives positive CHMP opinion
about 1 month ago
Prefilled syringe offers a convenient ready-to-use administration option to healthcare professionals.